|  | 
| Mechanism50S subunit inhibitors | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.United States | 
| First Approval Date01 Jun 1951 | 
100 Clinical Results associated with Alliance Boots GmbH
0  Patents (Medical) associated with Alliance Boots GmbH
100 Deals associated with Alliance Boots GmbH
100 Translational Medicine associated with Alliance Boots GmbH